Carbamazepine Tablet, Chewable
Product Images NDC 70518-1433

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 70518-1433). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy Label

Remedy Label
Carbamazepine is a chewable tablet medicine available in 100mg quantity. It is RX-only and comes in a bottle packaging of 30 tablets. The tablet is manufactured by Taro Pharma in Haifa Bay, Israel. It is necessary to keep this medicine and all other drugs out of children's access. For usage directions, refer to the package insert. This medicine should be stored between 20-25°C (88-77°F), but temperatures ranging between 15-30°C (59-86°F) can also be allowed. The tablet has been repackaged by RemedyRepack Inc. located in Indiana, Pennsylvania.*
FDA Label Image

Mm2 (Carbamazepine 100mg 70518 1433 01)

Mm2 (Carbamazepine 100mg 70518 1433 01)
Carbamazepine is a chewable tablet medication used for the treatment of certain types of seizures. This prescription medication comes in a bottle containing 180 tablets, with each tablet containing 100 mg of the active ingredient. The product should be stored between temperatures of 15-30°C, and kept away from children. Full instructions for use can be found in the package insert. The medicine is repackaged by RemedyRepack Ine.*
FDA Label Image

Chemical Structure (Carbamazepine 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.